Positron Corporation to acquire FDA 510(k) for NeuSight PET-CT from Neusoft subsidiary

Positron Corporation has entered an agreement to acquire the FDA 510(k) clearance for the NeuSight PET-CT imaging system from Neusoft Medical Systems' subsidiary Shenyang Intelligent Neuclear Medical Technology Co. The deal value was not disclosed.

“Gaining the 510(k) is a significant milestone in Positron’s mission to offer outstanding PET-CT technology and solutions to healthcare practices and hospitals serving both the cardiac and oncology segments of molecular imaging.”centralcharts.com

• 1 source
• centralcharts.comPositron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CTJun 12, 2024

Summarized from public sources; check the original articles before acting on it.